Patient-reported outcomes in Chinese patients with chronic myeloid leukemia receiving olverembatinib: Quality of life matters! Eskazan AE. Cancer 2025;131:e35737.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Eskazan AE. Patient-reported outcomes in Chinese patients with chronic myeloid leukemia receiving olverembatinib: Quality of life matters! Cancer 2025;131:e35737.
PMID: 39854042